跳至主要内容
临床试验/JPRN-UMIN000041583
JPRN-UMIN000041583已完成未知

A prospective observational study to evaluate the detection rate of actionable mutations by liquid biopsy Guardant360 in patients with non-squamous non-small cell lung cancer (NSCLC) whose gene alterations are not detected by tissue-based singleplex assays. (WJOG13620L) - A prospective observational study by G360 in NSCLC patients whose gene alterations are not deteted by tissue-based singleplex assays. (WJOG13620L)

West Japan Oncology Group0 个研究点目标入组 72 人开始时间: 2020年8月31日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Multiple cancer with metastasis. 2) Severe psychological disease. 3) Not fit for this trial judged by the doctor in charge.

研究者

相似试验